End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | +4.35% | -.--% | +33.33% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 42.01 | 8.997 | 7.541 |
Enterprise Value (EV) 1 | 42.24 | 10.66 | 10.25 |
P/E ratio | -4.14 x | -0.83 x | -1.19 x |
Yield | - | - | - |
Capitalization / Revenue | 17.8 x | 2.25 x | 15.8 x |
EV / Revenue | 17.9 x | 2.66 x | 21.4 x |
EV / EBITDA | -4.15 x | -1.03 x | -1.8 x |
EV / FCF | -5,533,599 x | -13,023,223 x | -14,022,284 x |
FCF Yield | -0% | -0% | -0% |
Price to Book | 32.2 x | -1.85 x | -0.89 x |
Nbr of stocks (in thousands) | 32,191 | 37,488 | 41,896 |
Reference price 2 | 1.305 | 0.2400 | 0.1800 |
Announcement Date | 22-05-02 | 23-06-15 | 24-05-07 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.3717 | 1.674 | 0.9794 | 2.357 | 4.002 | 0.4782 |
EBITDA 1 | -1.361 | -1.414 | -3.875 | -10.18 | -10.35 | -5.687 |
EBIT 1 | -1.378 | -1.432 | -3.893 | -10.21 | -10.38 | -5.711 |
Operating Margin | -370.83% | -85.51% | -397.46% | -433.35% | -259.45% | -1,194.3% |
Earnings before Tax (EBT) 1 | -1.882 | -1.497 | -7.716 | -8.78 | -10.35 | -5.807 |
Net income 1 | -1.882 | -1.497 | -7.716 | -8.78 | -10.35 | -5.807 |
Net margin | -506.2% | -89.4% | -787.89% | -372.52% | -258.56% | -1,214.54% |
EPS 2 | -0.4078 | -0.3244 | -1.078 | -0.3150 | -0.2901 | -0.1514 |
Free Cash Flow | - | -1.025 | -0.1451 | -7.633 | -0.8187 | -0.7308 |
FCF margin | - | -61.2% | -14.82% | -323.88% | -20.46% | -152.85% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 21-01-22 | 21-01-22 | 21-05-25 | 22-05-02 | 23-06-15 | 24-05-07 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.35 | 3.31 | 1.29 | 0.23 | 1.67 | 2.71 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -2.465 x | -2.338 x | -0.3317 x | -0.0226 x | -0.1609 x | -0.476 x |
Free Cash Flow | - | -1.02 | -0.15 | -7.63 | -0.82 | -0.73 |
ROE (net income / shareholders' equity) | - | 51% | 288% | 1,462% | 580% | 87.1% |
ROA (Net income/ Total Assets) | - | -105% | -213% | -203% | -170% | -254% |
Assets 1 | - | 1.419 | 3.622 | 4.33 | 6.097 | 2.287 |
Book Value Per Share 2 | -1.010 | -0.9100 | -0.1300 | 0.0400 | -0.1300 | -0.2000 |
Cash Flow per Share 2 | 0.0200 | 0.0200 | 0 | 0.0200 | 0 | 0 |
Capex 1 | 0 | 0.02 | 0.01 | 0.04 | 0.02 | - |
Capex / Sales | 0.39% | 1.46% | 1.02% | 1.58% | 0.58% | - |
Announcement Date | 21-01-22 | 21-01-22 | 21-05-25 | 22-05-02 | 23-06-15 | 24-05-07 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.33% | 11M | |
+11.85% | 8.05B | |
+4.94% | 7.59B | |
+2.63% | 6.07B | |
-2.80% | 3.85B | |
-11.22% | 3.55B | |
-7.04% | 1.28B | |
-32.50% | 1.03B | |
+12.52% | 971M | |
-11.19% | 907M |
- Stock Market
- Equities
- MUSL Stock
- Financials Promino Nutritional Sciences Inc.